Idiopathic Pulmonary Fibrosis

Medical ConditionIdiopathic Pulmonary Fibrosis
Facility/ClinicAccellacare – 1222 Medical Center Dr
Age40+
GenderMale & Female
DescriptionA study to measure the safety and efficacy of two different dosages of study medication versus placebo to treat Idiopathic Pulmonary Fibrosis.
EnrollmentOpen
Patient Commitment Durationminimum of 14 months – up to 4 years
Number of visits in study14+ visits
Patient Compensation$100/visit

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.